This case report chronicles a three-year journey of long COVID in a previously healthy 26-year-old, detailing treatment trials and near-total remission, but provides no new generalizable data.
1 citations
,
October 2022 in “Current Dermatology Reports” This review discusses various skin reactions after SARS-CoV-2 infection and COVID-19 vaccination, noting a higher incidence with mRNA vaccines than adenovirus vector vaccines, and reports no new clinical results.
7 citations
,
February 2022 in “The Journal of Dermatology” This case report suggests that the mRNA-1273 COVID-19 vaccine may induce systemic lupus erythematosus exacerbation, as observed in a 41-year-old woman who experienced worsened skin symptoms and other complications after vaccination.
October 2022 in “International Research Journal of Modernization in Engineering Technology and Science” This review discusses the development and rapid approval of COVID-19 vaccines and notes the observation of autoimmune disorders, such as alopecia areata, following vaccination; it provides no new clinical results.
2 citations
,
March 2022 in “PubMed” In this study, 19.6% of COVID-19 vaccine recipients reported post-vaccination mucocutaneous effects, mostly mild and self-limiting; the reactions were similarly frequent for Covishield and Covaxin.